Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorMagentiq Eye LTD
About this trial
This is an international, multicenter, study to evaluate the diagnostic performance of the CADx polyp sizing modality of the MAGENTIQ-COLO.
Eligibility criteria
Qualifiers
Individuals aged ≥45 - ≤80 years old, who are scheduled for non-iFOBT screening or surveillance colonoscopy.
Disqualifiers
In situ polyps with known histology detected in a previous colonoscopy.
No colorectal polyps detected during colonoscopy.
Known or suspected inflammatory bowel disease.
Polyposis syndrome (e.g., familial adenomatous polyposis, serrated polyposis).
Trial design
Treatments tested in this trial
- MAGENTIQ-COLO.
Treatment groups
330 Participants
are divided into 1 treatment groupLocations
5Israel
Assuta HaifaSelect State, Israel
Hadassah Medical Organization91120, Jerusalem Israel
Netherlands
Erasmus Medical Center3000 CA, Rotterdam Netherlands
United States
Johns Hopkins Hospital21202, BaltimoreMaryland, United States
Sponsors and collaborators
Magentiq Eye LTD
Lead sponsor
Source ClinicalTrials.gov